サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1799074

ワクチン物流の世界市場

Vaccine Logistics

出版日
ページ情報
英文 269 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=149.79円
ワクチン物流の世界市場
出版日: 2025年08月27日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 269 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

ワクチン物流の世界市場は2030年までに38億米ドルに達する見込み

2024年に30億米ドルと推定されるワクチン物流の世界市場は、2024年から2030年にかけてCAGR 4.0%で成長し、2030年には38億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである輸送サービスは、CAGR 3.8%を記録し、分析期間終了時には22億米ドルに達すると予想されます。倉庫サービス分野の成長率は、分析期間中CAGR 4.5%と推定されます。

米国市場は8億2,670万米ドル、中国はCAGR7.3%で成長予測

米国のワクチン物流市場は、2024年に8億2,670万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに7億7,890万米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは7.3%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.6%と3.2%と予測されています。欧州では、ドイツがCAGR 2.3%で成長すると予測されています。

世界のワクチン物流市場- 主要動向と促進要因のまとめ

ワクチン物流が他のコールドチェーン市場と比べて独特に複雑なのはなぜか？

ワクチン物流は、コールドチェーンロジスティクス業界において、超信頼性の温度管理、時間的制約のある流通、地域横断的な規制に準拠したトレーサビリティを要求される、独特のニッチを占めています。一般的な医薬品や生鮮品とは異なり、ワクチンは生物製剤であり、温度閾値が狭く（多くの場合2℃～8℃）、場合によっては（mRNAワクチンのように）-70℃での冷凍輸送を必要とします。これらの条件は、ファーストマイルの製造、ミッドマイルの航空／海上輸送、ラストマイルの診療所や予防接種センターへの配送を通して、継続的に維持されなければならないです。わずかな温度異常でさえワクチンを使用不能にする可能性があり、その結果、健康リスク、規制不遵守、経済的損失が生じる。

COVID-19ワクチンの展開により、ワクチン物流の規模と複雑さが明らかになり、超低温冷凍庫、IoT対応保温包装、可視化ソフトウェアへの投資が促進されました。パンデミックだけでなく、政府、ユニセフ、Gaviが管理する日常的な予防接種プログラムでは、遠隔地や十分なサービスを受けていない場所に年間数十億回分のワクチンを届ける必要があります。このため、特殊な断熱包装（相変化材料、真空断熱パネル）、パッシブ冷却ボックス、マルチモーダル連携が必要となります。また、未使用または期限切れの用量のリバースロジスティクスの管理、通関の効率化、各国の予防接種プログラムと世界保健機関との調整なども課題となっています。

ワクチン輸送・保管の未来を変えるテクノロジーとは？

ワクチン物流は、デジタルサプライチェーンプラットフォーム、リアルタイムの状態監視、AIによるルートプランニングによって変革されつつあります。ワクチンの包装や輸送容器に組み込まれたコネクテッドセンサー技術は、温度、湿度、振動、光照射をリアルタイムで監視します。これらのセンサーはBluetoothや携帯電話ネットワークを介してクラウドベースのダッシュボードにデータを送信し、プロアクティブなリスク軽減を可能にします。医薬品ロジスティクスプロバイダーは現在、AIアルゴリズムを使ってボトルネックを予測し、配送窓口を最適化し、天候や地政学的混乱に基づいて出荷を迂回させています。

もうひとつのイノベーションは、遠隔地や都市部の混雑した地域でのラストワンマイル配送のためのドローン物流と電気自動車（EV）の利用です。太陽光発電の保冷ボックスやポータブルワクチン冷蔵庫も、非電化地域で導入されています。データ分析によって予測や在庫計画が改善され、在庫切れやワクチンの無駄が削減されています。ブロックチェーンの試みは、ワクチンの出所、バッチ記録、規制監査証跡の改ざん防止追跡のために検討されています。これらのデジタルレイヤーは、特に規制の調和が不足しがちな国際的なワクチン取引において、信頼を構築するために不可欠です。

特殊化されたワクチン物流の需要が最も急増しているのはどこですか？

特殊なワクチン物流の需要は、先進国市場と新興国市場の両方で急増しており、予防接種スケジュールの拡大、成人ワクチンの摂取率、流行への備えの取り組みなどがその原動力となっています。高所得国では、季節性インフルエンザ、RSV、帯状疱疹、COVID-19ブースターのための強靭なコールドチェーンの構築に重点が置かれています。これらの地域では、スマート倉庫、温度管理された流通ハブ、ワクチン製造業者、流通業者、公衆衛生システム間のAPI統合にも投資しています。

中低所得国（LMICs）では、ラストワンマイルアクセス、コールドチェーン電化、官民物流パートナーシップの強化に重点が置かれています。COVAX、GaviのCold Chain Equipment Optimization Platform（CCEOP）、PATHのNextGenコールドチェーンソリューションなどの世界ヘルスイニシアチブが、ソーラー冷蔵庫、デジタルVVM（ワクチンバイアルモニター）、医療従事者向けトレーニングの導入を推進しています。サハラ以南のアフリカ、東南アジア、ラテンアメリカの国々は、投与量を追跡し、在庫を管理し、補充を計画するための国家的なワクチン物流管理システム（vLMIS）も採用しています。さらに、インド、中国、ブラジルでは国内でのワクチン製造が増加しており、国内でのコールドチェーン能力およびコンプライアンスシステムの必要性が高まっています。

世界のワクチン物流市場を前進させる力とは？

ワクチン物流市場の成長は、世界の予防接種プログラムの拡大、温度に敏感な生物製剤の需要増加、コールドチェーンインフラへの公共・民間投資の増加など、いくつかの要因によってもたらされています。COVID-19はパラダイムシフトをもたらし、世界のワクチン流通の脆弱性を露呈させ、より弾力的で俊敏、かつ追跡可能なロジスティクスシステムを構築する努力を促しました。各国政府は現在、パンデミック対策戦略や公衆衛生予算にコールドチェーン物流計画を組み込み、長期的な需要の安定を確保しています。

医薬品の技術革新も推進力の一つです。mRNAプラットフォーム、ベクターベースのワクチン、新規アジュバント製剤の成長に伴い、ワクチンの温度要件や取り扱い要件はより複雑になっています。このため、陸・空・海の各輸送形態における先進パッケージング、受動的冷却システム、能動的リーファー技術に対する需要が高まっています。さらに、WHOの事前認定から各国の適正流通規範（GDP）に至るまで、国際的な規制強化は、ロジスティクスプロバイダーに対し、品質保証、文書化、リスク管理の実践を強化するよう促しています。

医薬品ロジスティクスの新興企業に対するプライベートエクイティやベンチャーキャピタルの投資は、コールドチェーンのキャパシティを拡大するグローバルロジスティクスメジャー（DHL、UPS、Kuehne+Nagelなど）とともに、市場の関心の高まりをさらに反映しています。気候変動、世界の健康脅威、公平なワクチンアクセスへの要求が世界の健康情勢を再構築する中、市場情勢は、都市中心部から地方の前哨基地、そしてその間のあらゆる場所で、予防接種の成果を大規模に提供するための中心的存在であり続けるでしょう。

セグメント

サービス（輸送、倉庫、付加価値）、エンドユーザー（病院、医薬品メーカー・流通、その他エンドユーザー）

調査対象企業の例

  • 3PL-Agility
  • AIT Worldwide Logistics
  • AIT Worldwide Logistics
  • AllCargo Logistics
  • American Airlines Cargo
  • Americold Logistics
  • Biocair
  • CEVA Logistics
  • Cold Chain Technologies
  • DB Schenker
  • DHL Global Forwarding
  • DP World
  • DPD/Deutsche Post AG
  • Dulas Ltd.
  • FedEx Corporation
  • Gebruder Weiss
  • IndoSurgicals Pvt. Ltd.
  • Kuehne+Nagel
  • LifeConEx（DHL subsidiary）
  • Nippon Express

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP39474

Global Vaccine Logistics Market to Reach US$3.8 Billion by 2030

The global market for Vaccine Logistics estimated at US$3.0 Billion in the year 2024, is expected to reach US$3.8 Billion by 2030, growing at a CAGR of 4.0% over the analysis period 2024-2030. Transportation Service, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach US$2.2 Billion by the end of the analysis period. Growth in the Warehousing Service segment is estimated at 4.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$826.7 Million While China is Forecast to Grow at 7.3% CAGR

The Vaccine Logistics market in the U.S. is estimated at US$826.7 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$778.9 Million by the year 2030 trailing a CAGR of 7.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.6% and 3.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.3% CAGR.

Global Vaccine Logistics Market - Key Trends & Drivers Summarized

What Makes Vaccine Logistics Uniquely Complex Compared to Other Cold Chain Markets?

Vaccine logistics occupies a distinct niche within the cold chain logistics industry, demanding ultra-reliable temperature control, time-sensitive distribution, and regulatory-compliant traceability across geographies. Unlike general pharmaceuticals or perishables, vaccines are biologics with narrow thermal thresholds-often between 2°C and 8°C-and in some cases (like mRNA vaccines) requiring deep-frozen transport at -70°C. These conditions must be maintained continuously through first-mile manufacturing, mid-mile air/sea transport, and last-mile delivery to clinics or immunization centers. Even minor temperature excursions can render vaccines unusable, resulting in health risks, regulatory non-compliance, and financial losses.

COVID-19 vaccine deployment revealed the scale and complexity of vaccine logistics, driving investments in ultra-low temperature freezers, IoT-enabled thermal packaging, and visibility software. Beyond pandemics, routine immunization programs managed by governments, UNICEF, and Gavi require annual delivery of billions of doses to remote and underserved locations. This necessitates specialized packaging (phase-change materials, vacuum insulation panels), passive cooling boxes, and multi-modal coordination. Challenges also include managing reverse logistics for unused or expired doses, ensuring customs clearance efficiency, and coordinating between national immunization programs and global health agencies.

Which Technologies Are Reshaping the Future of Vaccine Transport and Storage?

Vaccine logistics is being transformed by digital supply chain platforms, real-time condition monitoring, and AI-assisted route planning. Connected sensor technologies embedded in vaccine packaging or transport containers monitor temperature, humidity, vibration, and light exposure in real time. These sensors transmit data via Bluetooth or cellular networks to cloud-based dashboards, enabling proactive risk mitigation. Pharmaceutical logistics providers now use AI algorithms to predict bottlenecks, optimize delivery windows, and reroute shipments based on weather or geopolitical disruptions.

Another innovation is the use of drone logistics and electric vehicles (EVs) for last-mile delivery in remote or urban-congested areas. Solar-powered cold boxes and portable vaccine refrigerators are also being deployed in off-grid regions. Data analytics is improving forecasting and inventory planning, reducing both stockouts and vaccine wastage. Blockchain pilots are being explored for tamper-proof tracking of vaccine provenance, batch records, and regulatory audit trails. These digital layers are essential to building trust, especially in international vaccine trade, where regulatory harmonization is often lacking.

Where Is the Demand for Specialized Vaccine Logistics Growing Most Rapidly?

Demand for specialized vaccine logistics is surging across both developed and emerging markets, driven by expanded immunization schedules, adult vaccine uptake, and epidemic preparedness initiatives. In high-income countries, the focus is on building resilient cold chains for seasonal influenza, RSV, shingles, and COVID-19 boosters. These regions are also investing in smart warehousing, temperature-controlled distribution hubs, and API integrations between vaccine manufacturers, distributors, and public health systems.

In low- and middle-income countries (LMICs), the emphasis is on last-mile access, cold chain electrification, and strengthening of public-private logistics partnerships. Global health initiatives-such as COVAX, Gavi’s Cold Chain Equipment Optimization Platform (CCEOP), and PATH’s NextGen cold chain solutions-are driving deployment of solar refrigerators, digital VVMs (vaccine vial monitors), and training for health workers. Countries in Sub-Saharan Africa, Southeast Asia, and Latin America are also adopting national vaccine logistics management systems (vLMIS) to track doses, manage inventories, and plan replenishments. Additionally, domestic vaccine manufacturing growth in India, China, and Brazil is increasing the need for intra-national cold chain capacity and compliance systems.

What Forces Are Powering the Global Vaccine Logistics Market Forward?

The growth in the vaccine logistics market is driven by several factors, including expanded global immunization programs, rising demand for temperature-sensitive biologics, and increasing public and private investment in cold chain infrastructure. COVID-19 created a paradigm shift, exposing vulnerabilities in global vaccine distribution and catalyzing efforts to build more resilient, agile, and traceable logistics systems. National governments are now incorporating cold chain logistics planning into pandemic preparedness strategies and public health budgets, ensuring long-term demand stability.

Pharmaceutical innovation is another driver. With the growth of mRNA platforms, vector-based vaccines, and novel adjuvanted formulations, the temperature and handling requirements of vaccines are becoming more complex. This is stimulating demand for advanced packaging, passive cooling systems, and active reefer technologies across land, air, and sea modes. Moreover, international regulatory tightening-from WHO prequalification to national Good Distribution Practices (GDP)-is pushing logistics providers to enhance quality assurance, documentation, and risk management practices.

Private equity and venture capital investment in pharmaceutical logistics startups, along with global logistics majors expanding cold chain capacity (e.g., DHL, UPS, Kuehne+Nagel), further reflect growing market interest. As climate change, global health threats, and demand for equitable vaccine access reshape the global health landscape, the vaccine logistics market will remain central to delivering immunization outcomes at scale-across urban centers, rural outposts, and everything in between.

SCOPE OF STUDY:

The report analyzes the Vaccine Logistics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Service (Transportation Service, Warehousing Service, Value-Added Services); End-User (Hospitals End-User, Drug Manufacturers & Distributors End-User, Other End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

  • 3PL-Agility
  • AIT Worldwide Logistics
  • AIT Worldwide Logistics
  • AllCargo Logistics
  • American Airlines Cargo
  • Americold Logistics
  • Biocair
  • CEVA Logistics
  • Cold Chain Technologies
  • DB Schenker
  • DHL Global Forwarding
  • DP World
  • DPD/Deutsche Post AG
  • Dulas Ltd.
  • FedEx Corporation
  • Gebruder Weiss
  • IndoSurgicals Pvt. Ltd.
  • Kuehne+Nagel
  • LifeConEx (DHL subsidiary)
  • Nippon Express

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Vaccine Logistics - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Global Vaccination Campaigns Throw the Spotlight on Scalable and Resilient Vaccine Logistics Infrastructure
    • Expansion of Cold Chain Networks Spurs Growth in Temperature-Controlled Storage and Transportation Solutions
    • Rising Demand for Last-Mile Delivery Efficiency Expands Addressable Market for Specialized Vaccine Distribution Services
    • Innovation in Temperature Monitoring and IoT Integration Strengthens the Business Case for Smart Vaccine Logistics
    • Increasing Use of mRNA and Biologic Vaccines Drives Adoption of Ultra-Cold Chain Logistics Technologies
    • Emerging Markets Push for Immunization Equity Fuels Investment in Rural and Remote Area Distribution Capabilities
    • Integration with National Immunization Programs Enhances Demand Forecasting and Inventory Management Systems
    • Growth in Outsourcing by Pharma Companies Supports Expansion of Specialized Vaccine Logistics Providers
    • Standardization of Packaging, Labeling, and Handling Protocols Improves Cross-Border Vaccine Movement
    • Real-Time Visibility and Exception Management Tools Improve Cold Chain Integrity and Risk Mitigation
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Vaccine Logistics Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Vaccine Logistics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Vaccine Logistics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Vaccine Logistics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Transportation Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Transportation Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Transportation Service by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Warehousing Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Warehousing Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Warehousing Service by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Value-Added Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Value-Added Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Value-Added Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Hospitals End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Hospitals End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Hospitals End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Drug Manufacturers & Distributors End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Drug Manufacturers & Distributors End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Drug Manufacturers & Distributors End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Vaccine Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • JAPAN
    • Vaccine Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • CHINA
    • Vaccine Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 43: China 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 46: China 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • EUROPE
    • Vaccine Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Vaccine Logistics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Vaccine Logistics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Vaccine Logistics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • FRANCE
    • Vaccine Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 58: France 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 61: France 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • GERMANY
    • Vaccine Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Vaccine Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Vaccine Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Vaccine Logistics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Vaccine Logistics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Vaccine Logistics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Vaccine Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • INDIA
    • Vaccine Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 115: India 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 118: India 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Vaccine Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Vaccine Logistics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Vaccine Logistics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Vaccine Logistics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Vaccine Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Vaccine Logistics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Vaccine Logistics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Vaccine Logistics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • AFRICA
    • Vaccine Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030

IV. COMPETITION